728x90
반응형
■ Ertugliflozin – Ertugliflozin is taken once daily in the morning with or without food. The initial dose is 5 mg once daily and may be increased to a maximum dose of 15 mg once daily to achieve glycemic goals. Ertugliflozin is contraindicated in patients with an eGFR <30 mL/min and is not recommended in patients with eGFR of 30 to <60 mL/min. In patients taking ertugliflozin who have a persistent fall in eGFR below 60 mL/min, it should be discontinued.
REF. UpToDate 2018.11.15
728x90
반응형
'내분비내과 > 당뇨병' 카테고리의 다른 글
| 최소한의 체중 증가 또는 체중 감소를 위한 당뇨병 약제 선택 (0) | 2018.11.17 |
|---|---|
| 제2형 당뇨병과 CKD가 있는 환자에서 SGLT2 억제제 (0) | 2018.11.17 |
| 제2형 당뇨병 환자에서 ASCVD와 심부전이 함께 있거나 심부전이 특별히 고려될 때 (0) | 2018.11.08 |
| Management of Hyperglycemia in T2DM, 2018. A Consensus Report by the ADA and EASD (4) (0) | 2018.11.06 |
| Management of Hyperglycemia in T2DM, 2018. A Consensus Report by the ADA and EASD (3) (0) | 2018.11.06 |
